The U.S. Food and Drug Administration has parted ways with its chief spokeswoman, according to a person with knowledge of the move, after the head of the agency exaggerated the
Continue reading »Home »
Controversial Alzheimer’s Drug Takes Step Toward FDA Approval
Biogen Inc.’s experimental Alzheimer’s disease treatment aducanumab was granted priority review status by U.S. regulators, a move that could hasten the drug’s arrival on the market. The company said in
Continue reading »U.S. Cases Rise 1%; Trump Defends Malaria Drug: Virus Update
Flare-ups in virus cases from Hong Kong to Europe are proving difficult for policy makers to wrangle. The U.S. neared 150,000 deaths from Covid-19, even as daily infections slowed in
Continue reading »